Confronto

Carbetocin vs. Histrelin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

37025-55-1

220810-26-4

Peso molecolare

nessun dato

1323.52 g/mol

Emivita

0.67 h

nessun dato

Sequenza

nessun dato

Meccanismo d'azione

Carbetocin

Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.

Histrelin

Continuous GnRH-agonist stimulation downregulates and desensitises the pituitary GnRH receptors — after the initial rise, LH, FSH and the sex hormones fall persistently.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Carbetocin	Histrelin
Germania	Su prescrizione	Su prescrizione
Stati Uniti	Non approvato	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Carbetocin and Histrelin?: Carbetocin is classified as "Ricerca (altro)", while Histrelin is classified as "Ricerca (altro)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Histrelin: Histrelin is a nonapeptide GnRH agonist delivered as a once-yearly implant. Approved for central precocious puberty in children (Supprelin LA) and advanced prostate cancer (Vantas). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Carbetocin or Histrelin?: The highest available evidence level is "RCT sull'uomo" for Carbetocin and "RCT sull'uomo" for Histrelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Carbetocin and Histrelin in Germany and the United States?: Germania: Carbetocin — Su prescrizione, Histrelin — Su prescrizione. Stati Uniti: Carbetocin — Non approvato, Histrelin — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Carbetocin

Histrelin

Germania

Su prescrizione

Stati Uniti

Non approvato

Su prescrizione

Frequently asked questions

What is the difference between Carbetocin and Histrelin?

Carbetocin is classified as "Ricerca (altro)", while Histrelin is classified as "Ricerca (altro)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Histrelin: Histrelin is a nonapeptide GnRH agonist delivered as a once-yearly implant. Approved for central precocious puberty in children (Supprelin LA) and advanced prostate cancer (Vantas). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Carbetocin or Histrelin?

The highest available evidence level is "RCT sull'uomo" for Carbetocin and "RCT sull'uomo" for Histrelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Carbetocin and Histrelin in Germany and the United States?

Germania: Carbetocin — Su prescrizione, Histrelin — Su prescrizione. Stati Uniti: Carbetocin — Non approvato, Histrelin — Su prescrizione. These are factual summaries with source and review date on the individual pages.